With 1 year of use, improvements seen in asthma outcomes.
Burden of new pediatric asthma cases accounts for 13% of global incidence.
Genetic evidence shows elevated SHBG levels may protect against asthma, mostly in females.
Omega fatty acid intake also modifies effect of indoor PM exposure on respiratory symptoms
People living in homes with high average air exchange rates are more likely to report chronic cough, asthma, or asthma-like symptoms..
A new electronic decision support tool can improve the quality of asthma care in primary care settings.
The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the US FDA.
Overweight/obese teens, young adults taking supplements do not have improved asthma control.
Odds of being undiagnosed higher for girls, Asian-Americans vs white non-Hispanics.
The combined use of mometasone furoate and formoterol in adults and adolescents with persistent asthma may not increase asthma-related adverse events and may reduce the risk of worsening asthma outcomes.
Clinicians are gaining a better understanding of how asthma and allergies are regulated by the circadian clock, which will help patients better alleviate their symptoms.
Omalizumab rescue therapy produced rapid results in a patient with refractory status asthmaticus.
Bronchoscopic lung volume reduction with valve replacement shows the most promise for improving lung function, exercise tolerance, and quality of life in patients with advanced emphysema.
Gaps in insurance coverage increased the odds of asthma-related emergency department intervention or hospitalization and exacerbations.
Facilitator-led sites had a higher percentage of patients who reported equal participation with their provider in making asthma treatment decisions vs the lunch-and-learn sites.
Adolescents with asthma treated with dupilumab experienced significant improvements in FEV1 compared with placebo.
Benralizumab was associated with a significant reduction in annual asthma exacerbation rates.
Montelukast plus levocetirizine demonstrated a significant reduction in mean daytime nasal symptom scores compared with montelukast monotherapy.
The most common error related to the use of metered dose inhalers was the failure to attach the inhaler to a spacer.
Total serum bilirubin levels of 9 to 11.9 mg/dL, 12 to 14.9 mg/dL, and 15 to 17.9 mg/dL were associated with significantly greater risks for asthma in infants.